Histoplasma capsulatum fails to trigger release of superoxide from macrophages
- 1 January 1987
- journal article
- research article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 55 (1) , 29-34
- https://doi.org/10.1128/iai.55.1.29-34.1987
Abstract
The yeast form of the dimorphic fungus Histoplasma capsulatum survives within macrophages after phagocytosis. To do so, it must avoid, inhibit, or resist a variety of toxic oxygen metabolites. Using ferricytochrome c reduction to assay superoxide release, we examined the response of mouse macrophages to the yeast form of various H. capsulatum strains. Doses of zymosan as low as 20 particles per macrophage elicited superoxide, whereas H. capsulatum failed to induce superoxide even at 160 yeast cells per macrophage. This phenomenon was observed with two virulent strains of H. capsulatum (G217B and G186A) and with an avirulent variant of G186A. Over a 15- to 150-min observation period, zymosan stimulated increasing reduction of ferricytochrome c, but H. capsulatum did not. When added concurrently with zymosan, H. capsulatum had no effect on superoxide production. Therefore, H. capsulatum was unable either to inactivate the oxygen radical or inhibit host cell superoxide response to other competent stimuli. Enzymatically generated superoxide reduced ferricytochrome c even in the presence of H. capsulatum, again implying that the organism does not readily inactivate superoxide. This experiment also demonstrated that the yeast did not interfere with the assay used. Thus, rather than inhibiting superoxide generation or inactivating the anion, H. capsulatum yeast cells appear to avoid the toxic effects of superoxide by failing to trigger its release.This publication has 44 references indexed in Scilit:
- Interaction of human monocytes, macrophages, and polymorphonuclear leukocytes with zymosan in vitro. Role of type 3 complement receptors and macrophage-derived complement.Journal of Clinical Investigation, 1985
- The respiratory burst of phagocytes.Journal of Clinical Investigation, 1984
- Dissociation of phagocytosis from stimulation of the oxidative metabolic burst in macrophages.The Journal of Experimental Medicine, 1984
- Receptors for C3b and C3bi promote phagocytosis but not the release of toxic oxygen from human phagocytes.The Journal of Experimental Medicine, 1983
- Yeast Mannans inhibit binding and phagocytosis of zymosan by mouse peritoneal macrophagesThe Journal of cell biology, 1983
- Mechanisms of superoxide Radical-mediated toxicityJournal of Toxicology: Clinical Toxicology, 1982
- Failure to trigger the oxidative metabolic burst by normal macrophages: possible mechanism for survival of intracellular pathogens.The Journal of Experimental Medicine, 1980
- Virulence and Resistance to Superoxide, Low pH and Hydrogen Peroxide among Strains of Mycobacterium tuberculosisJournal of General Microbiology, 1978
- EFFECT OF NORMAL AND ACTIVATED HUMAN MACROPHAGES ON TOXOPLASMA GONDII The Journal of Experimental Medicine, 1974
- THE DIFFERENTIATION OF MONONUCLEAR PHAGOCYTESThe Journal of Experimental Medicine, 1965